Professor Khalid Khan: EBM

Research Questions and Genuine Evidence Gaps

Professor Khalid Khan — Thu, 18 Jun 2026 13:16:54 GMT

Defining Knowledge Needs: The Pitfall of Broad Objectives in Clinical Research

When medical students, junior clinicians, PhD candidates, and early-career researchers embark on their first research projects, they frequently encounter a hurdle before data collection even begins. The most important errors made during the initial planning of any research project is formulating a question that is too broad, too ambiguous, or purely descriptive.

Many students present simple, vague intentions—such as wanting to evaluate "the referral pattern to a tertiary healthcare setting". While tracking proportions or identifying basic associated factors seems logical on the surface, an unstructured question lacks the scientific precision required to clear institutional review boards, secure funding, or achieve high-impact publication.

Why Vague Research Hypotheses Fail Institutional Approval

A research protocol cannot survive the scrutiny of a Research Ethics Committee or an Institutional Review Board if its core question remains loose. Vague objectives create downstream flaws in the research execution and reporting:

Methodological Ambiguity: Without a specific hypothesis, it is mathematically impossible to calculate an accurate sample size. Without a specified participant group it become difficult to define clear inclusion and exclusion criteria.
Scope Ambivalence: Broad questions lead to chaotic data collection, forcing researchers to gather hundreds of irrelevant variables that fail to address a concrete knowledge need.
Ethical Rejection: Research Ethics Boards routinely reject protocols that cannot demonstrate how their data collection directly translates into scholarly inquiry with potential for developing actionable public health solutions.

Step-by-Step Solution: Structuring Questions with the PICO Framework

A descriptive concept, initially worded as a lay query, must be converted into scientific objectives by transforming it into a structured question. The standard for clinical and epidemiological research questions is the PICO or PECO framework. Transforming your research question requires breaking it down into four components:

P – Participants: Define the exact patient cohort, demographic, and disease type to be evaluated. Often the term “population” is used, but this is an error as research is carried out on samples, not on populations.
I – Intervention (or E – Exposure): Specify the primary exposure, diagnostic test, clinical treatment, or referral trigger.
C – Comparison: Establish the explicit control group or standard against which the intervention is measured. It may be no intervention, standard of care, another intervention, placebo, etc.
O – Outcome: Detail the precise, measurable clinical results, proportions, or metrics tracked during follow up.

By mapping an initial idea directly onto these four pillars, a loose objective is instantly transformed into a precise, scientifically valid clinical inquiry as demonstrated in the discussion a medical student from Khyber Medical College, Pakistan.

Scoping-Mapping Searches

Once the initial question is framed, a scoping literature search can be carried out. It allows us to check if out question has not already been addressed. This we we can avoid redundant effort or we can judicially plan replications. By identifying previously published literature, we can also refine our initially framed question, more precisely defining each one of its components. The process of reviewing the literature to refine a research question is called a scoping review and the to define a research gap is called a mapping review. Scoping and mapping reviews are publishable pieces of work in their own right.

Registration

Once the structured question is firmed up, a hypothesis established and a protocol drafted, institutional approval is obtained. In some circumstances, e.g. when conducting meta-analyses projects, approval may not be required or exemption may be granted by the review board. The next stage, before starting the research project, involves public pre-registration. Read the registration guide:

Professor Khalid Khan

How to Register Your Research on OSF

7 days ago · Professor Khalid Khan

The Take-Home Message

Scientific and publishing success is underpinned by the precision of your initial research question or hypothesis. Moving away from vague descriptive queries and adopting structured frameworks for outlining specific research objectives protects against flawed methodology, satisfies institutional review boards, and guarantees that your data and analysis will serve a concrete purpose, generating evidence useful for evidence-based medicine.

Subscribe now

📺 Watch the companion video (YouTube):
https://youtu.be/j3rofONWUAk

📊 Download the companion slides (SlideShare): https://www.slideshare.net/slideshow/formulating-research-questions-and-defining-evidence-gaps/289220093

🎓 Citable resource (ResearchGate):
DOI: 10.13140/RG.2.2.33929.20323

🤖 AI Disclosure:

This article utilizes an ethical, hybrid workflow. The core scientific content is based on the author’s original video, slides, and research expertise. Generative AI tools were utilized to transcribe, structure, and refine the readability of the raw text under strict human editorial supervision. All factual claims, research findings, methodological guidance, and professional judgements are the author’s own. This approach is consistent with COPE guidelines on AI use in academic content, which require disclosure of AI assistance without granting AI authorship status. The final text was reviewed and approved by Professor Khalid Khan prior to publication.

💡 About the Author:

Professor Khalid Khan, former Beatriz Galindo Distinguished Investigator at the University of Granada, Spain, has been Professor at the University of Birmingham and the Queen Mary University of London, UK, and Spinoza Professor at the University of Amsterdam, the Netherlands. Drawing from three decades of real-world research experience, Professor Khan is recognized among the top 2% most influential scientists in the world.

📚 Advance Your Research Career:
Explore Professor Khan's academic volumes (CRC Press / Routledge):
• "Responsible Research Conduct: What Investigations into Alleged Research Misconduct tell us about Scientific Integrity" — An objective operational roadmap to prevent fraud, address misconduct, and protect the scientific record.
• "Systematic Reviews to Support Evidence-Based Medicine: How to appraise, conduct and publish reviews" — A step-by-step guide for evidence synthesis that is an award-winning book.
• "Integrity of Randomized Clinical Trials: How to prevent research misconduct and ensure transparency" — The first book on clinical trial integrity that provides clear guidance on how to ensure openness and transparency.
• "Health Research Translation: Making Science Useful for Practicing Evidence-based Medicine" — A definitive guide bridging the gap between clinical data collection, citizen involvement, and practical bedside healthcare application.

🌐 Connect & Explore More Resources:
• Official Training Portal & Masterclasses on Professor Khalid Khan's YouTube Educational Hub
• Institutional Inquiries: Reach out via profkkhan@gmail.com • Professional Network: Connect with Professor Khan on LinkedIn

Conflict of interest: Professor Khalid Khan is a director of Health Education Research (HER Ltd).

This work is shared under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

Research Waste: The Disaster Destroying Evidence-based Medicine

Professor Khalid Khan — Fri, 22 May 2026 15:06:06 GMT

Research Waste: The Preventable Disaster Destroying Modern Medicine

The Shocking Scale of Research Waste

In the global healthcare academic community, billions are spent annually on generating medical literature. However, an alarmingly large percentage of this effort yields no real-world impact. It has been estimated that around 85% of research is completely wasted. When we consider that there are thousands of scientific journals dedicated to medicine, life sciences, and biomedicine, this represents a massive loss of investment and data that fails to improve healthcare outcomes.

The Stages of the Research Life Cycle Where Evidence is Lost

Research waste accumulates across the entire research life cycle—from the initial problem formulation to study conduct, ethics registration, and the final publication stage. The critical failure points can be broken down into distinct areas:

Failure to Publish Registered Studies: A significant portion of approved and registered clinical trials are never published. Studies show that a notable percentage of registered trials remain unpublished long after completion.
Flaws in Design and Methodology: Many published studies suffer from high risks of bias, imprecision, unreliability, and heterogeneity. When data collection neglects the correct population subsets or measures irrelevant interventions, the research fails to deviate from systematic errors.
Incomplete and Poor Reporting: Even when a study is conducted well, a lack of transparency and poor reporting of methodologies render the data unusable. Many publications fail to meet basic consensus reporting standards.

The Challenge of Knowledge Transfer

The ultimate goal of evidence-based medicine is knowledge transfer—getting high-quality research into clinical practice guidelines to improve patient care. Unfortunately, a massive portion of the published literature in specialized fields is never utilized in guidelines.

While these flawed or irrelevant articles may serve to expand the curriculum vitae of their authors and accumulate academic citations, they never contribute to any structural changes in healthcare settings.

The Take-Home Message

Modern healthcare research cannot afford to operate on wasted investments. Addressing research waste requires strict methodological integrity and public involvement in planning hypotheses. Without transparency and proper reporting, valuable medical evidence will remain locked away, never making it into actual practice.

Subscribe now

🤖 AI Disclosure:
This article utilizes an ethical, hybrid workflow. The core scientific content is based on the author’s original video, slides, and research expertise. Generative AI tools were utilized to transcribe, structure, and refine the readability of the raw text under strict human editorial supervision. All factual claims, research findings, methodological guidance, and professional judgements are the author's own. This approach is consistent with COPE guidelines on AI use in academic content, which require disclosure of AI assistance without granting AI authorship status. The final text was reviewed and approved by Professor Khalid Khan prior to publication.

💡 About the Author:
Professor Khalid Khan, former Beatriz Galindo Distinguished Investigator at the University of Granada, Spain, has been Professor at the University of Birmingham and the Queen Mary University of London, UK, and Spinoza Professor at the University of Amsterdam, the Netherlands.Drawing from three decades of real-world research experience, Professor Khan is recognized among the top 2% most influential scientists in the world.

🌐 Connect & Explore More Resources:
• Institutional Inquiries: Reach out via profkkhan@gmail.com
• Official Training Portal & Masterclasses on Professor Khalid Khan's YouTube Educational Hub
• Professional Network: Connect with Professor Khan on LinkedIn

Conflict of interest: Professor Khalid Khan is a director of Health Education Research (HER Ltd).

This work is shared under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

Understanding Epidemiology: The Core of Public Health

Professor Khalid Khan — Sat, 30 Aug 2025 16:37:00 GMT

How Epidemiology Transmutes Public Health Uncertainty Into Verifiable Evidence

What is Epidemiology?

Epidemiology is the cornerstone of public health practice and research. Epidemiology is widely recognized as the cornerstone and structural foundation of public health practice and clinical research. It is defined as the systematic, data-driven study of the distribution and determinants of health-related states or events within specified human populations. Rather than treating individual patients on a case-by-case basis, epidemiology views the entire community as its collective patient. By rigorously analyzing statistical data, tracking disease frequency, and identifying risk patterns, epidemiologists uncover the vital evidence required to shape global health policies, design preventative strategies, and manage ongoing healthcare crises before they reach a point of no return.

Epidemic versus Pandemic: Knowing the Difference

In public health, clear definitions are crucial for effective communication and resources. In the realm of global health security, precise terminology is critical for direct resource allocation, political mobilization, and public risk communication. Outbreaks are classified systematically based on geographic scale and population density rather than arbitrary numerical thresholds:

Epidemic: A sudden increase in the number of cases of a disease. This operational term describes a sudden, unexpected spike in the incidence of a specific disease within a localized population, community, or geographic region. An epidemic occurs when the observed number of cases significantly exceeds the baseline “expected” levels historically recorded for that specific time and place.
Pandemic: An epidemic that has spread over several countries or continents. A pandemic is an epidemic that has completely crossed international borders, spreading over multiple countries, continents, or worldwide. It typically affects a massive proportion of the global population. Pandemics present severe systemic challenges because they deal with widespread community transmission, often involving novel pathogens where population immunity is nonexistent.

The Role of Epidemiological Data in Clinical Decisions

Robust epidemiological research allows health authorities to make evidence-based policy decisions. Professor Khalid Khan introduces the basics of epidemiology, explaining its importance to public health. This epidemiology lecture covers crucial concepts related to disease and medical research and provides a solid foundation for anyone interested in understanding how we study the distribution and determinants of health-related states or events in specified populations. The discussion also touches upon evidence-based medicine.

Robust epidemiological research is the active engine behind evidence-based medicine. Clinical decisions made in isolation lack the contextual awareness needed to control transmissible or chronic conditions across populations. Comprehensive data collection, allowing for explicit cross-examinations of environmental exposure, social determinants, and transmission dynamics, enables health authorities to implement targeted interventions. Without accurate epidemiological metrics and open data sharing, public health policies risk being misdirected, which results in wasted scientific infrastructure and a significant failure in public health protection.

Professor Khalid Khan

The Broken Pipeline Between Discovery and Patient Care: Bridging the Research-Practice Gap

a year ago · Professor Khalid Khan

The Take-Home Message

Public health strategies rely entirely on accurate epidemiological tracking. To control outbreaks before they escalate, global cooperation and transparent data sharing are essential. Modern public health strategies cannot rely on guesswork. Turning uncertainty into verifiable evidence through field epidemiology is our only reliable shield against emerging global health threats. Systematic tracking and statistical transparency are non-negotiable tools to control disease transmission and preserve global health security.

Subscribe now

💡 About the Author:
This article was written and curated by Professor Khalid Khan, former Beatriz Galindo Distinguished Investigator at the University of Granada, Spain. Drawing from three decades of real-world research experience, Professor Khan is recognized among the top 2% most influential scientists in the world.

This work is shared under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

The Evidence Hierarchy: The Medical Research You Can Trust!

Professor Khalid Khan — Sat, 05 Jul 2025 18:18:00 GMT

The Medical Evidence Ladder: How Study Design Determines What We Can Trust

Surviving the Information Avalanche in Healthcare

In modern clinical practice, medical professionals do not suffer from a lack of information. Instead, they face an overwhelming information avalanche. There are thousands of biomedical journals indexing millions of articles annually through online databases. Within the standard PubMed repository alone, thousands of new citations are added daily.

To practice true evidence-based medicine (EBM), clinicians must be able to quickly separate the wheat from the chaff. They require an efficient rule-of-thumb—a heuristic—to quickly classify literature as either evidentiary or non-evidentiary. This foundational rule of thumb is known as the medical evidence hierarchy.

What is Study Design and Why Does It Create Levels?

The absolute foundation of the evidence ladder is the study design. A study design is simply the specific methodology used to conduct an evaluation. Typically, a clinical study extracts a sample of patients from a broader target population. Following individual informed consent and strict approval by an institutional ethics committee, the participants are monitored to track specific clinical outcomes.

The primary reason the evidence hierarchy uses study design to sort research is to evaluate validity. Validity means that the results obtained are mathematically true for the specific sample recruited. If a study design is structurally weak, its conclusions will suffer from bias and systematic error, rendering the results invalid for shaping public health policies or local clinical guidelines.

The Classic Pillars of the Evidence Ladder

The traditional evidence hierarchy ranks research methods based on their inherent ability to control for bias. The most valid, bias-free designs are positioned highest on the ladder:

Level 1 — Randomized Controlled Trials (RCTs): These stand as the highest form of primary evidence. By allocating patients to separate groups entirely at random, RCTs ensure that baseline variables are perfectly comparable, allowing researchers to isolate true clinical causation.
Level 2 — Controlled Observational Studies: These are utilized when randomization is unethical or impractical. This bracket includes Cohort Studies (where exposed and unexposed groups are followed forward) and Case-Control Studies (which look backward from an outcome).
Non-Evidentiary Data: While case reports, case series, laboratory research, and expert consensus opinions provide initial exploratory ideas, they lack a comparative control setup. Therefore, they do not possess true evidentiary value and are discarded when evaluating clinical effectiveness.

Professor Khalid Khan

Understanding Study Design: Navigating Mislabeled Studies

5 years ago · Professor Khalid Khan

Refining the Ladder: Balancing Validity and Precision

While the legacy evidence hierarchy looked exclusively at primary studies, modern developments have expanded the ladder. The volume of secondary literature has grown immensely, allowing systematic reviews to become a central column of evidence-based practice.

Because of this, contemporary evidence hierarchies evaluate two distinct core metrics: Validity (the truth of the method) and Precision (the width of the confidence interval around a result). By leveraging secondary analysis, the levels of evidence are refined into sub-brackets:

Level 1A vs. Level 1B Evidence

An individual randomized trial provides solid validity, but its sample size may limit its precision, ranking it as Level 1B evidence. When a Systematic Review uses Meta-Analysis to combine several primary RCTs into a single paper, it mathematically tightens the confidence intervals. This combination creates a combined result with a much greater level of precision, establishing the gold standard known as Level 1A evidence.

Level 2A vs. Level 2B Evidence

This exact same precision rule applies to weaker observational studies. A standalone, independent cohort study provides Level 2B evidence. However, executing a systematic meta-analysis of comparative cohort data pools the individual metrics together to deliver an advanced Level 2A ranking.

The Take-Home Message

Evidence-based medicine requires clinicians to balance the art of personal judgement with the rigorous science of empirical data. By mastering the evidence hierarchy as a practical screening tool, you can rapidly filter through the daily avalanche of biomedical publications. Evaluating both validity and precision through meta-analyses ensures that your healthcare decisions remain grounded in the absolute highest tier of scientific truth.

Subscribe now

🤖 AI Disclosure:
This article utilizes an ethical, hybrid workflow. The core scientific content is based on the author’s original video, slides, and research expertise. Generative AI tools were utilized to transcribe, structure, and refine the readability of the raw text under strict human editorial supervision. All factual claims, research findings, methodological guidance, and professional judgements are the author's own. This approach is consistent with COPE guidelines on AI use in academic content, which require disclosure of AI assistance without granting AI authorship status. The final text was reviewed and approved by Professor Khalid Khan prior to publication.

💡 About the Author:
Professor Khalid Khan, former Beatriz Galindo Distinguished Investigator at the University of Granada, Spain, has been Professor at the University of Birmingham and the Queen Mary University of London, UK, and Spinoza Professor at the University of Amsterdam, the Netherlands. Drawing from three decades of real-world research experience, Professor Khan is recognized among the top 2% most influential scientists in the world.

Conflict of interest: Professor Khalid Khan is a director of Health Education Research (HER Ltd).

This work is shared under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

The Broken Pipeline Between Discovery and Patient Care: Bridging the Research-Practice Gap

Professor Khalid Khan — Sun, 08 Jun 2025 11:30:00 GMT

From Published Studies to Clinical Guidelines: Understanding how Evidence becomes Medical Practice

The Structural Breakdown of Healthcare Knowledge Translation

In the academic world, billions are spent annually generating medical literature across biomedicine, life sciences, and social sciences. However, a critical problem persists in contemporary healthcare: a staggering amount of empirical research goes completely unused, failing to ever reach the patient's bedside.

Instead of moving smoothly from discovery to application, valuable scientific insights are routinely lost in a leaky implementation and knowledge transfer pipeline. To optimize clinical outcomes, healthcare systems must dismantle this research-practice gap by mastering the distinct evolutionary stages of data mobilization.

Demystifying the Evidence-Based Medicine (EBM) Glossary

Understanding how to get research into practice requires breaking down the core vocabulary of patient-centered healthcare research. While several terms are used interchangeably in the literature, they feature unique structural focuses:

Evidence-Based Medicine (EBM) & Evidence-Based Practice (EBP)

These frameworks prioritize the care of individual patients. EBM provides a systematic way of thinking and a clinical modus operandi where individual clinicians frame clear questions, search databases to bridge knowledge gaps, appraise literature using strict quality hierarchies, and apply useful empirical data on the job.

Evidence-Based Healthcare (EBHC)

This broader concept expands EBM beyond medical doctors to encapsulate all health professionals, including evidence-based nursing, physiotherapy, and complementary therapies.

Knowledge Transfer (KT) & Knowledge Mobilization

Unlike individual patient care, KT emphasizes entire health services and systems. It focuses on how collective scientific evidence can be deployed by committees to construct hospital care protocols, clinical practice guidelines, and systemic public health policies.

Translational Research (Research Translation)

This represents the chronological journey from the laboratory bench to the patient's bedside. It charts the movement from basic lab research (evaluating cells, organ systems, and animal models) to applied, patient-centered human research.

The Stages of the Translational Research Continuum

The journey from a laboratory discovery to a societal healthcare impact is not a straight line; it is an iterative process that moves back and forth across specific translational milestones:

T1 Translation (Efficacy): Moving from basic laboratory or animal research to early human evaluation to establish the proof of principle and clinical efficacy. This aligns with phase one and phase two feasibility and pilot clinical trials.
T2 Translation (Effectiveness): Advancing from tightly controlled efficacy models to evaluating real-world clinical effectiveness across multi-center and multi-country phase three clinical trials.
T3 Translation (Evidence Synthesis): Executing rigorous systematic reviews, meta-analyses, and the grading of evidence to synthesize scattered applied data into official clinical guidelines.
T4 Translation (Implementation and Impact): Auditing how well guidelines are being utilized in health services to achieve genuine, long-term health improvements in society.

Navigating the Knowledge Transfer Pipeline

To prevent data from leaking out of the clinical pipeline, health systems must systematically transition evidence through an explicit sequence of steps:

Published Papers ➡️ Journal Clubs/Awareness ➡️ Opinion Leaders/Persuasion ➡️ Guidelines and Care Protocols ➡️ Implementation ➡️ Shared Decision-Making ➡️ Patient Adherence ➡️ Health Impact

The process begins when clinicians build awareness of published literature through targeted reading or journal clubs. Opinion leaders must then persuade colleagues to employ this data in hospital decision-making. Once formal care protocols are prepared, true implementation occurs.

Crucially, clinicians must execute shared decision-making jointly with the patient to ensure they understand and adhere to the guideline. Finally, to ensure opportunities are never missed, health services must implement continuous audit and feedback loops.

Professor Khalid Khan

The Evidence Hierarchy: The Medical Research You Can Trust!

a year ago · Professor Khalid Khan

The Take-Home Message

Patients expect clinicians to seamlessly combine the art of medicine—clinical experience, intuition, and belief judgments—with empirical, data-driven science. By mastering the frameworks of translational research and fixing the leaks in our knowledge transfer pipelines, the academic world can ensure its massive scientific investments successfully transform into high-integrity, real-world patient care.

Subscribe now

🤖 AI Disclosure:
This article utilizes an ethical, hybrid workflow. The core scientific content is based on the author’s original video, slides, and research expertise. Generative AI tools were utilized to transcribe, structure, and refine the readability of the raw text under strict human editorial supervision. All factual claims, research findings, methodological guidance, and professional judgements are the author's own. This approach is consistent with COPE guidelines on AI use in academic content, which require disclosure of AI assistance without granting AI authorship status. The final text was reviewed and approved by Professor Khalid Khan prior to publication.

💡 About the Author:
Professor Khalid Khan, former Beatriz Galindo Distinguished Investigator at the University of Granada, Spain, has been Professor at the University of Birmingham and the Queen Mary University of London, UK, and Spinoza Professor at the University of Amsterdam, the Netherlands. Drawing from three decades of real-world research experience, Professor Khan is recognized among the top 2% most influential scientists in the world.

Conflict of interest: Professor Khalid Khan is a director of Health Education Research (HER Ltd).

This work is shared under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).